A randomized, bilateral, controlled, prospective study to investigate the efficacy of corneal shape customised versus standard whole central cornea riboflavin/ultraviolet A corneal collagen cross-linking
- Conditions
- Keratoconus, corneal ectasiaEye DiseasesKeratoconus
- Registration Number
- ISRCTN52187987
- Lead Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped
- Sex
- All
- Target Recruitment
- 34
1. Progressive keratoconus defined by an increase in refractive astigmatism, maximum keratometry, apex power of the cone by more than 1 diopter and/or a decrease in central corneal pachymetry by 10% in the preceding 2 years to 18 months
2. Grade I-III keratoconus (3mm keratometry less than 55 diopters, cone apex power less than 70 diopters, central pachymetry greater than 400um)
3. Age over 18
1. Advanced keratoconus (3mm keratometry greater than 55 diopters, cone apex power greater than 70 diopters, central pachymetry less than 400um)
2. Pregnancy
3. Corneal scarring
4. Co-existant ocular pathology other than keratoconus
5. Age less than 18
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> Change in:<br> 1. Refractive error (diopters)<br> 2. Topographic simulated keratometry (diopters) (corneal curvature)<br> 3. Maximum keratometry (Kmax)<br> 4. Posterior corneal curvature<br> 5. Pentacam-derived keratoconus indices<br> 6. Belin-Ambrosio enhanced ectasia scores<br> 7. Corneal pachymetry (micrometers)<br> 8. Visual acuity (logMar)<br> Measured at baseline 6, 12 and 18 months<br>
- Secondary Outcome Measures
Name Time Method <br> Stability in:<br> 1. Refractive error (diopters)<br> 2. Topographic simulated keratometry (diopters) (corneal curvature)<br> 3. Maximum keratometry (Kmax)<br> 4. Posterior corneal curvature<br> 5. Pentacam-derived keratoconus indices<br> 6. Belin-Ambrosio enhanced ectasia scores<br> 7. Corneal pachymetry (micrometers)<br> 8. Visual acuity (logMar)<br> 9. Endothelial cell counts<br> 10. Sight-threatening complications<br> Measured at baseline 6, 12 and 18 months<br>